Back to top

Eloxx Pharmaceuticals initiated with an Outperform at LifeSci Capital

LifeSci Capital analyst Rami Katkhuda initiated coverage of Eloxx Pharmaceuticals (ELOX) with an Outperform rating and $40 price target Published f...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Senesco Technologies Inc. (ELOX)